Ghafoor, Bushra http://orcid.org/0000-0001-7879-8364
Masthan, Shameera Shaik http://orcid.org/0000-0001-5185-1575
Hameed, Maha http://orcid.org/0000-0001-8066-4584
Akhtar, Hafiza Huda http://orcid.org/0000-0001-9037-1945
Khalid, Azeem http://orcid.org/0000-0002-7205-7140
Ghafoor, Sana http://orcid.org/0000-0002-6072-5754
Allah, Hassan min http://orcid.org/0000-0003-0210-1238
Arshad, Mohammad Mohsin http://orcid.org/0000-0001-5426-1925
Iqbal, Iman
Iftikhar, Ahmad http://orcid.org/0000-0002-2358-7057
Husnain, Muhammad http://orcid.org/0000-0001-7248-9835
Anwer, Faiz http://orcid.org/0000-0001-6914-7439
Article History
Received: 16 February 2023
Accepted: 26 June 2023
First Online: 6 July 2023
Declarations
:
: Not applicable.
: Faiz Anwer Reports personalities from Bristol Myers Squibb as a speaker and feeds from Janssen pharmaceutical as an advisory board member; these fevers are unrelated to the submitted work. Without receiving direct funding, served as the local principal investigator for Allogene Therapeutics, Celgene, GlaxoSmithKline, and Bristol Myers Squibb; has a consulting on an advisory role for Seattle genetics, Incyte Corporation speakers Bureau, Company: Insight Corporation; receives travel and accommodations expenses from Seattle genetics, insight; receives on the radio from insight, complaining: Seattle genetics; and received research funding from Seattle Genetics, company: Calgene, Acetylon pharmaceuticals, Millennium, Astellas Pharma and AbbVie; and reports no other potential conflicts of interest for this work. The other authors declare no competing interests.